{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:32:22Z","timestamp":1787610742132,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.trim.2026.102396","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:33:48Z","timestamp":1777577628000},"page":"102396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Association of HLA alleles and mismatches with post-transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"96","author":[{"given":"Sara","family":"Assadiasl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Mojtahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Safdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Mami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Sadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes","family":"Soleimanifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Nicknam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.trim.2026.102396_bb0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2500\/aap.2024.45.240063","article-title":"Overview of secondary immunodeficiency","volume":"45","author":"Herman","year":"2024","journal-title":"Allergy Asthma Proc."},{"issue":"1","key":"10.1016\/j.trim.2026.102396_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","article-title":"Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.trim.2026.102396_bb0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hon.3139","article-title":"Post-transplant lymphoproliferative disease in children, adolescents, and young adults","volume":"41","author":"Gross","year":"2023","journal-title":"Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.trim.2026.102396_bb0020","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.trim.2026.102396_bb0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.trim.2026.102396_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40588-019-00120-9","article-title":"Epstein-Barr virus and the human leukocyte antigen complex","volume":"6","author":"Li","year":"2019","journal-title":"Curr. Clin. Microbiol. Rep."},{"issue":"8","key":"10.1016\/j.trim.2026.102396_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004309","article-title":"Assembly and architecture of the EBV B cell entry triggering complex","volume":"10","author":"Sathiyamoorthy","year":"2014","journal-title":"PLoS Pathog."},{"issue":"16","key":"10.1016\/j.trim.2026.102396_bb0040","doi-asserted-by":"crossref","first-page":"9252","DOI":"10.1073\/pnas.160171697","article-title":"Coreceptor restriction within the HLA-DQ locus for Epstein\u2013Barr virus infection","volume":"97","author":"Haan","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.trim.2026.102396_bb0045","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85687","article-title":"HLA-DQ \u03b21 alleles associated with Epstein-Barr virus (EBV) infectivity and EBV gp42 binding to cells","volume":"2","author":"Li","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.trim.2026.102396_bb0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cid\/cis823","article-title":"Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study","volume":"56","author":"H\u00f6cker","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.trim.2026.102396_bb0055","doi-asserted-by":"crossref","first-page":"9923","DOI":"10.1038\/s41598-017-10265-6","article-title":"TCR\u2013like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus\u2013transformed B lymphoblastoid cells expressing different HLA-A* 02 microvariants","volume":"7","author":"Lai","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.trim.2026.102396_bb0060","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood-2007-05-086934","article-title":"HLA-A* 02 is associated with a reduced risk and HLA-A* 01 with an increased risk of developing EBV+ Hodgkin lymphoma","volume":"110","author":"Niens","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.trim.2026.102396_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039986","article-title":"HLA associations in classical Hodgkin lymphoma: EBV status matters","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.trim.2026.102396_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174457","article-title":"HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients","volume":"12","author":"Fletcher","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2026.102396_bb0075","first-page":"1","article-title":"Host control of persistent Epstein-Barr virus infection","author":"Schmidt","year":"2026","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.trim.2026.102396_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pathol.2019.09.006","article-title":"Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review","volume":"52","author":"Marques-Piubelli","year":"2020","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.trim.2026.102396_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2010.10.016","article-title":"Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants","volume":"63","author":"Stojanova","year":"2011","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.trim.2026.102396_bb0090","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.tp.0000235889.05171.12","article-title":"Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantation","volume":"82","author":"Subklewe","year":"2006","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.trim.2026.102396_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.trim.2026.102396_bb0100","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"issue":"20","key":"10.1016\/j.trim.2026.102396_bb0105","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.trim.2026.102396_bb0110","series-title":"Newcastle-Ottawa Quality Assessment Scale Cohort Studies","author":"Wells","year":"2014"},{"issue":"3","key":"10.1016\/j.trim.2026.102396_bb0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/TP.0b013e3181e46a22","article-title":"Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report","volume":"90","author":"Opelz","year":"2010","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.trim.2026.102396_bb0120","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/01.TP.0000062571.56977.26","article-title":"Risk of lymphoid neoplasia after cardiothoracic transplantation: the influence of underlying disease and human leukocyte antigen type and matching","volume":"75","author":"Higgins","year":"2003","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2026.102396_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.TP.0000128611.71038.0C","article-title":"Epstein-Barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative disease","volume":"78","author":"Wong","year":"2004","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.trim.2026.102396_bb0130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.tp.0000173793.03228.bd","article-title":"HLA antigens and post renal transplant lymphoproliferative disease: HLA-B matching is critical","volume":"80","author":"Bakker","year":"2005","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.trim.2026.102396_bb0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.trim.2026.102396_bb0140","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1164\/rccm.200804-531OC","article-title":"Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival","volume":"178","author":"Wheless","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.trim.2026.102396_bb0145","first-page":"16","article-title":"Associations of Human Leukocyte Antigen (HLA) haplotypes with risk of developing lymphoproliferative disorders after renal transplantation","volume":"12","author":"Pourfarziani","year":"2007","journal-title":"Ann. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2026.102396_bb0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3345\/kjp.2017.60.3.86","article-title":"Posttransplantation lymphoproliferative disorder after pediatric solid organ transplantation: experiences of 20 years in a single center","volume":"60","author":"Jeong","year":"2017","journal-title":"Korean J. Pediatr."},{"issue":"10","key":"10.1016\/j.trim.2026.102396_bb0155","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.healun.2020.06.010","article-title":"Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: analysis of ISHLT registry","volume":"39","author":"Zaffiri","year":"2020","journal-title":"J. Heart Lung Transplant."},{"issue":"4","key":"10.1016\/j.trim.2026.102396_bb0160","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1600-6143.2011.03454.x","article-title":"Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients","volume":"11","author":"Reshef","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2026.102396_bb0165","doi-asserted-by":"crossref","first-page":"262","DOI":"10.21608\/ejhm.2023.279537","article-title":"Human leucocyte antigen A alleles in the prediction of post-kidney transplant lymphoproliferative disorders, a single-center study","volume":"90","author":"Magar","year":"2023","journal-title":"Egypt. J. Hosp. Med."},{"issue":"6","key":"10.1016\/j.trim.2026.102396_bb0170","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/TP.0000000000000487","article-title":"Human leukocyte antigen type and posttransplant lymphoproliferative disorder","volume":"99","author":"Lustberg","year":"2015","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.trim.2026.102396_bb0175","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3109\/10428194.2016.1173209","article-title":"Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder","volume":"57","author":"Kinch","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"21","key":"10.1016\/j.trim.2026.102396_bb0180","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1182\/blood.V116.21.5074.5074","article-title":"Posttransplant lymphoproliferative disorders (PTLD) after renal transplantation: Focus on HLA Antigens","volume":"116","author":"Strandhave","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.trim.2026.102396_bb0185","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1182\/blood.V110.11.4421.4421","article-title":"A single-centre experience of clinico-pathological features, risk factors and treatment outcome of posttransplant lymphoproliferative disorders (PTLD) after renal transplantation","volume":"110","author":"Sondergaard","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.trim.2026.102396_bb0190","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/ctr.12252","article-title":"Post-transplant lymphoproliferative disorder after pancreas transplantation: a United Network for Organ Sharing database analysis","volume":"27","author":"Jackson","year":"2013","journal-title":"Clin. Transpl."},{"issue":"7","key":"10.1016\/j.trim.2026.102396_bb0195","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000534","article-title":"HLA associations and risk of posttransplant lymphoproliferative disorder in a Danish population-based cohort","volume":"1","author":"Vase","year":"2015","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.trim.2026.102396_bb0200","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13737-016-0036-1","article-title":"Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation","volume":"5","author":"Rausch","year":"2016","journal-title":"Transp. Res."},{"issue":"4","key":"10.1016\/j.trim.2026.102396_bb0205","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/tri.12744","article-title":"Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study","volume":"29","author":"Maksten","year":"2016","journal-title":"Transpl. Int."},{"issue":"2","key":"10.1016\/j.trim.2026.102396_bb0210","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.trim.2015.02.005","article-title":"HLA class I associations with EBV+ post-transplant lymphoproliferative disorder","volume":"32","author":"Jones","year":"2015","journal-title":"Transpl. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2026.102396_bb0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.athoracsur.2017.09.033","article-title":"Posttransplant lymphoproliferative disorders in Epstein-Barr virus donor positive\/recipient negative lung transplant recipients","volume":"105","author":"Courtwright","year":"2018","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.trim.2026.102396_bb0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States","volume":"86","author":"Quinlan","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.trim.2026.102396_bb0225","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.ajkd.2011.07.015","article-title":"Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses","volume":"58","author":"Kasiske","year":"2011","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.trim.2026.102396_bb0230","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/TP.0b013e3181c69855","article-title":"Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation","volume":"89","author":"Opelz","year":"2010","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.trim.2026.102396_bb0235","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1097\/TP.0000000000001025","article-title":"HLA and risk of diffuse large B cell lymphoma after solid organ transplantation","volume":"100","author":"Hussain","year":"2016","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2026.102396_bb0240","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1526924819835834","article-title":"Incidence, risk factors, clinical management, and outcomes of posttransplant lymphoproliferative disorder in kidney transplant recipients","volume":"29","author":"Liu","year":"2019","journal-title":"Prog. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2026.102396_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13151","article-title":"Pediatric renal transplantation: a retrospective single-center study on epidemiology and morbidity due to EBV","volume":"22","author":"Laurent","year":"2018","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2026.102396_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.866407","article-title":"An HLA map of the world: A comparison of HLA frequencies in 200 worldwide populations reveals diverse patterns for class I and class II","volume":"14","author":"Arrieta-Bola\u00f1os","year":"2023","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.trim.2026.102396_bb0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5581\/1516-8484.20120010","article-title":"HLA-A, B and DRB1 allele and haplotype frequencies in volunteer bone marrow donors from the north of Parana State","volume":"34","author":"Bardi","year":"2012","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"1","key":"10.1016\/j.trim.2026.102396_bb0260","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1038\/s41598-020-62175-9","article-title":"HLA-A, -B, -C, -DRB1, -DQA1, and -DQB1 allele and haplotype frequencies defined by next generation sequencing in a population of East Croatia blood donors","volume":"10","author":"Toki\u0107","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.trim.2026.102396_bb0265","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/ajt.15177","article-title":"HLA-DR\/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity","volume":"19","author":"Wiebe","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.trim.2026.102396_bb0270","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/tri.13657","article-title":"Molecular-level HLA mismatch is associated with rejection and worsened graft survival in heart transplant recipients\u2013a retrospective study","volume":"33","author":"Osorio-Jaramillo","year":"2020","journal-title":"Transpl. Int."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:50:09Z","timestamp":1780296609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"alternative-id":["S0966327426000547"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102396","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of HLA alleles and mismatches with post-transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102396"}}